The impact of myasthenia gravis severity on work and daily activities
- 13 February 2024
- journal article
- research article
- Published by Wiley in Muscle & Nerve
- Vol. 69 (4) , 428-439
Abstract
Introduction/Aims: People with myasthenia gravis (MG) experience impaired quality of life. However, the impact of MG symptoms on work productivity has not been well‐studied. We aimed to evaluate this impact and to examine associations between disease severity and the degree of impairment.Methods: Data were drawn from the Adelphi MG Disease‐Specific Programme™, a multinational (USA, France, Germany, Italy, Spain, UK) survey completed by physicians and their patients with MG in 2020. Patient‐reported measures included the Work Productivity and Activity Impairment (WPAI): Specific Health Problem questionnaire.Results: The WPAI questionnaire was completed by 330 patients. Among those currently employed, the mean percentage of work time missed (absenteeism) was 13.3% (N = 116), percentage impairment of productivity at work (presenteeism) was 26.7% (N = 121), and overall work impairment was 30.0% (N = 110). Across all patients, impairment of non‐work‐related activities due to health problems (ADL impairment) was 39.2% (N = 330). Regression analysis indicated that impairment differed according to MG Foundation of America (MGFA) class (p = .0147, p < .0001, p < .0001 and p < .0001 for absenteeism, presenteeism, overall work impairment and ADL impairment, respectively). Being MGFA class III/IV was a predictor of presenteeism, overall work impairment and ADL impairment in a predictor model.Discussion: Patients with MG experience substantial work impairment particularly those with more severe symptoms, highlighting an important way in which patient quality of life is negatively affected. More effective treatment strategies would enable patients to lead more productive lives and could impact decisions relating to work and career.Keywords
Funding Information
- Janssen Scientific Affairs
This publication has 23 references indexed in Scilit:
- Productivity loss and productivity loss costs to United States employers due to priority conditions: a systematic reviewJournal of Medical Economics, 2023
- Academic and Employment Status in Patients With Generalized Myasthenia Gravis Treated With Eculizumab: A Case SeriesJournal of Clinical Neuromuscular Disease, 2022
- The humanistic burden of myasthenia gravis: A systematic literature reviewJournal of the Neurological Sciences, 2022
- Identifying a patient‐centered outcome measure for a comparative effectiveness treatment trial in myasthenia gravisMuscle & Nerve, 2021
- Self-reported work productivity in people with multiple sclerosis and its association with mental and physical healthDisability and Rehabilitation, 2021
- A Global Assessment of Eye Health and Quality of LifeJAMA Ophthalmology, 2021
- The impact of seven major noncommunicable diseases on direct medical costs, absenteeism, and presenteeism in Gulf Cooperation Council countriesJournal of Medical Economics, 2021
- Generalized Myasthenia GravisNeurologic Clinics, 2018
- Direct and indirect cost of myasthenia gravis: A prospective study from a tertiary care teaching hospital in IndiaJournal of Clinical Neuroscience, 2017
- The substantial burden of systemic lupus erythematosus on the productivity and careers of patients: a European patient-driven online surveyRheumatology, 2013